Efficacy News and Research

RSS
Tarsa advances OSTORA NDA filing through $28M Series B financing

Tarsa advances OSTORA NDA filing through $28M Series B financing

SK Biopharmaceuticals initiates YKP10811 phase 2 trial in chronic constipation

SK Biopharmaceuticals initiates YKP10811 phase 2 trial in chronic constipation

CCN1 protein orchestrates cellular antiviral response in the extracellular matrix

CCN1 protein orchestrates cellular antiviral response in the extracellular matrix

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

Abbott initiates enrollment in two HUMIRA Phase 3 trials for moderate to severe HS

CSL Behring initiates FCH Phase III trial to control bleeding during cardiovascular surgery

CSL Behring initiates FCH Phase III trial to control bleeding during cardiovascular surgery

FDA clears Alma Lasers' novel approach for treatment of nail fungus

FDA clears Alma Lasers' novel approach for treatment of nail fungus

Longer looks: Last interview with Oregon's assisted-suicide law architect; Med students spurn primary care for hospital jobs

Longer looks: Last interview with Oregon's assisted-suicide law architect; Med students spurn primary care for hospital jobs

Shire enters agreement to acquire FerroKin BioSciences

Shire enters agreement to acquire FerroKin BioSciences

Potential efficacy of specialized psychotherapy in bulimia nervosa and binge eating disorder

Potential efficacy of specialized psychotherapy in bulimia nervosa and binge eating disorder

Fecal transplantation effective treatment for recurrent C. difficile infection

Fecal transplantation effective treatment for recurrent C. difficile infection

Bayer HealthCare receives FDA approval for Natazia to treat HMB

Bayer HealthCare receives FDA approval for Natazia to treat HMB

New national effort to accelerate development of therapies for neurological diseases

New national effort to accelerate development of therapies for neurological diseases

Homeopathy could soon be declared “baseless and unethical” in Australia

Homeopathy could soon be declared “baseless and unethical” in Australia

Scientists track genetic pathway of prostate cancer in new approach to drug discovery

Scientists track genetic pathway of prostate cancer in new approach to drug discovery

Bend Research announces licensing agreement with Affinium

Bend Research announces licensing agreement with Affinium

Inovio achieves strong T cell immune responses in PENNVAX-B Phase I HIV study

Inovio achieves strong T cell immune responses in PENNVAX-B Phase I HIV study

Positive results from Bausch + Lomb, NicOx BOL‑303259‑X phase 2b study on OAG

Positive results from Bausch + Lomb, NicOx BOL‑303259‑X phase 2b study on OAG

Medivir initiates two new HPC3001 and HPC3011 phase III trials in HCV

Medivir initiates two new HPC3001 and HPC3011 phase III trials in HCV

FTY720 improves locomotor recovery in mice with SCI

FTY720 improves locomotor recovery in mice with SCI

Reviva to initiate enrollment in RP503 phase 2 study for schizophrenia

Reviva to initiate enrollment in RP503 phase 2 study for schizophrenia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.